reverse semaglutide A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% As a provider who has

Fourth, catabolic intermediatesbranched-chain -keto acids (BCKAs) and branched-chain acylcarnitines (BCACs)accumulate when BCKDH flux is impaired and exert independent pathological effects that are mechanistically distinct from those of BCAAs per se

Keep reading Published on: June 23, 2026 Wellstar Kennestone Opens Next-Generation NICU Designed for Babies and Families Few moments are more challenging for a parent than learning their newborn needs specialized medical care

Tipoe, M

eat slowly

Up to 97% of NAION patients have small optic discs with small or absent cups, representing the strongest risk factor

The goal is to maintain hemoglobin A1c below 7% for most adults, though individualized targets may vary based on age, comorbidities, and hypoglycemia risk, according to the ADA Standards of Care